Bank Of America Corp Bellus Health Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.14 - $8.53 $949,341 - $1.13 Million	132,961 Added 147.75%	222,953 $1.61 Million
Q4 2022 Feb 10, 2023	BUY	$8.22 - $10.76 $189,512 - $248,071	23,055 Added 34.44%	89,992 $739,000
Q3 2022 Nov 14, 2022	SELL	$8.95 - $12.0 $101,913 - $136,644	-11,387 Reduced 14.54%	66,937 $708,000
Q2 2022 Aug 12, 2022	SELL	$6.46 - $10.02 $77,248 - $119,819	-11,958 Reduced 13.25%	78,324 $723,000
Q1 2022 May 16, 2022	BUY	$5.56 - $7.99 $367,955 - $528,770	66,179 Added 274.57%	90,282 $622,000
Q4 2021 Feb 08, 2022	BUY	$5.26 - $8.3 $126,781 - $200,054	24,103 New	24,103 $194,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.